Amgen Czech Republic made a net profit of CZK 35.8 mil in 2015, down 11.4% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 46.2 mil in 2011 and an all time low of CZK 9.88 mil in 2007.
This implies return on equity of 18.4% and return on invested capital of 36.6% in 2015. That is compared to 20.6% and 38.1% average seen in the last five years.
Since 2010, net profit of the firm increased by -5.28% or -1.08% a year on average.
As far as Amgen Czech Republic's peers are concerned, Roche Czech Republic generated ROE of 4.40% and ROCE of 2.65% in 2015 Bayer Czech Republic's profitability reached 50.6% and 29.0%, respectively..